Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: Wiener klinische Wochenschrift 1-2/2022

03.05.2021 | original article

Diabetic foot complications—lessons learned from real-world data derived from a specialized Austrian hospital

verfasst von: Sophia Rossboth, Benedikt Rossboth, Hans Schoenherr, Christian Ciardi, Monika Lechleitner, Willi Oberaigner

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 1-2/2022

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

Background

Diabetic foot complications, one of the most severe late complications of type 2 diabetes mellitus, are associated with a tremendous personal and financial burden. In order to drive the prevention of diabetic foot complications forward and facilitate early detection and personalized screening of high-risk patients, longitudinal studies are needed to identify risk factors associated with diabetic foot complications in large patient datasets.

Methods

This is a retrospective cohort study on 3002 patients with type 2 diabetes mellitus aged ≥ 18 years without prior foot complications. The data were collected between 2006 and 2017 in an Austrian hospital department specialized for diabetic patients. In addition to a univariate Cox regression analysis, multivariate Cox regression models were established to identify independent risk factors associated with diabetic foot complications and adjust for potential confounders.

Results

We observed a total of 61 diabetic foot complications in 3002 patients. In the multivariate Cox regression model, significant risk factors (hazard ratio, 95% confidence interval) for foot complications were age at diagnosis > 70 years (3.39, 1.33–8.67), male gender (2.55, 1.42–4.55), neuropathy (3.03, 1.74–5.27), peripheral arterial disease (3.04, 1.61–5.74), hypertension > 10 years after diagnosis (2.32, 1.09–4.93) and HbA1c > 9% (2.44, 1.02–5.83).

Conclusion

The identified risk factors for diabetic foot complications suggest that personalized early detection of patients at high risk might be possible by taking the patient’s clinical characteristics, medical history and comorbidities into account. Modifiable risk factors, such as hypertension and high levels of blood glucose might be tackled to reduce the risk for diabetic foot complications.
Literatur
1.
Zurück zum Zitat Federation IDIDF. Diabetes Atlas. 9th ed. 2019. Federation IDIDF. Diabetes Atlas. 9th ed. 2019.
2.
Zurück zum Zitat Boulton AJ, Armstrong DG, Albert SF, Frykberg RG, Hellman R, Kirkman MS, et al. Comprehensive foot examination and risk assessment. Diabetes Care. 2008;31(8):1679–85. PubMedPubMedCentral Boulton AJ, Armstrong DG, Albert SF, Frykberg RG, Hellman R, Kirkman MS, et al. Comprehensive foot examination and risk assessment. Diabetes Care. 2008;31(8):1679–85. PubMedPubMedCentral
3.
Zurück zum Zitat Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293(2):217–28. PubMed Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293(2):217–28. PubMed
4.
Zurück zum Zitat Prompers L, Huijberts M, Schaper N, Apelqvist J, Bakker K, Edmonds M, et al. Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study. Diabetologia. 2008;51(10):1826. PubMed Prompers L, Huijberts M, Schaper N, Apelqvist J, Bakker K, Edmonds M, et al. Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study. Diabetologia. 2008;51(10):1826. PubMed
5.
Zurück zum Zitat Volmer-Thole M, Lobmann R. Neuropathy and diabetic foot syndrome. IJMS. 2016;17(6):917. PubMedCentral Volmer-Thole M, Lobmann R. Neuropathy and diabetic foot syndrome. IJMS. 2016;17(6):917. PubMedCentral
7.
Zurück zum Zitat Boyko EJ, Ahroni JH, Smith DG, Davignon D. Increased mortality associated with diabetic foot ulcer. Diabet Med. 1996;13(11):967–72. PubMed Boyko EJ, Ahroni JH, Smith DG, Davignon D. Increased mortality associated with diabetic foot ulcer. Diabet Med. 1996;13(11):967–72. PubMed
9.
Zurück zum Zitat de Meneses LC, Blanes L, Francescato Veiga D, Carvalho Gomes H, Ferreira ML. Health-related quality of life and self-esteem in patients with diabetic foot ulcers: results of a cross-sectional comparative study. Ostomy Wound Manag. 2011;57(3):36. de Meneses LC, Blanes L, Francescato Veiga D, Carvalho Gomes H, Ferreira ML. Health-related quality of life and self-esteem in patients with diabetic foot ulcers: results of a cross-sectional comparative study. Ostomy Wound Manag. 2011;57(3):36.
10.
Zurück zum Zitat Salomé GM, de Souza Pellegrino DM, Blanes L, Ferreira LM. Self-esteem in patients with diabetes mellitus and foot ulcers. J Tissue Viability. 2011;20(3):100–6. PubMed Salomé GM, de Souza Pellegrino DM, Blanes L, Ferreira LM. Self-esteem in patients with diabetes mellitus and foot ulcers. J Tissue Viability. 2011;20(3):100–6. PubMed
11.
Zurück zum Zitat Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93(1):137–88. PubMed Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93(1):137–88. PubMed
12.
Zurück zum Zitat Hex N, Bartlett C, Wright D, Taylor M, Varley D. Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabet Med. 2012;29(7):855–62. PubMed Hex N, Bartlett C, Wright D, Taylor M, Varley D. Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabet Med. 2012;29(7):855–62. PubMed
13.
Zurück zum Zitat Jeffcoate WJ, Harding KG. Diabetic foot ulcers. lancet. 2003;361(9368):1545–51. PubMed Jeffcoate WJ, Harding KG. Diabetic foot ulcers. lancet. 2003;361(9368):1545–51. PubMed
14.
Zurück zum Zitat Driver VR, Fabbi M, Lavery LA, Gibbons G. The costs of diabetic foot: the economic case for the limb salvage team. J Vasc Surg. 2010;52(3):17S–22S. PubMed Driver VR, Fabbi M, Lavery LA, Gibbons G. The costs of diabetic foot: the economic case for the limb salvage team. J Vasc Surg. 2010;52(3):17S–22S. PubMed
15.
Zurück zum Zitat Bus SA, van Netten JJ. A shift in priority in diabetic foot care and research: 75 % of foot ulcers are preventable. Diabetes Metab Res Rev. 2016;32:195–200. PubMed Bus SA, van Netten JJ. A shift in priority in diabetic foot care and research: 75 % of foot ulcers are preventable. Diabetes Metab Res Rev. 2016;32:195–200. PubMed
16.
Zurück zum Zitat Litzelman DK, Slemenda CW, Langefeld CD, Hays LM, Welch MA, Bild DE, et al. Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus: a randomized, controlled trial. Ann Intern Med. 1993;119(1):36–41. PubMed Litzelman DK, Slemenda CW, Langefeld CD, Hays LM, Welch MA, Bild DE, et al. Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus: a randomized, controlled trial. Ann Intern Med. 1993;119(1):36–41. PubMed
17.
Zurück zum Zitat Boyko EJ, Ahroni JH, Cohen V, Nelson KM, Heagerty PJ. Prediction of diabetic foot ulcer occurrence using commonly available clinical information: the Seattle Diabetic Foot Study. Diabetes Care. 2006;29(6):1202–7. PubMed Boyko EJ, Ahroni JH, Cohen V, Nelson KM, Heagerty PJ. Prediction of diabetic foot ulcer occurrence using commonly available clinical information: the Seattle Diabetic Foot Study. Diabetes Care. 2006;29(6):1202–7. PubMed
18.
Zurück zum Zitat Monteiro-Soares M, Boyko EJ, Ribeiro J, Ribeiro I, Dinis-Ribeiro M. Predictive factors for diabetic foot ulceration: a systematic review. Diabetes Metab Res Rev. 2012;28(7):574–600. PubMed Monteiro-Soares M, Boyko EJ, Ribeiro J, Ribeiro I, Dinis-Ribeiro M. Predictive factors for diabetic foot ulceration: a systematic review. Diabetes Metab Res Rev. 2012;28(7):574–600. PubMed
20.
Zurück zum Zitat Sauseng S, Kästenbauer T, Sokol G, Irsigler K. Estimation of risk for plantar foot ulceration in diabetic patients with neuropathy. Diabetes Nutr Metab. 1999;12(3):189–93. PubMed Sauseng S, Kästenbauer T, Sokol G, Irsigler K. Estimation of risk for plantar foot ulceration in diabetic patients with neuropathy. Diabetes Nutr Metab. 1999;12(3):189–93. PubMed
21.
Zurück zum Zitat Kästenbauer T, Sauseng S, Sokol G, Auinger M, Irsigler K. A prospective study of predictors for foot ulceration in type 2 diabetes. J Am Podiatr Med Assoc. 2001;91(7):343–50. PubMed Kästenbauer T, Sauseng S, Sokol G, Auinger M, Irsigler K. A prospective study of predictors for foot ulceration in type 2 diabetes. J Am Podiatr Med Assoc. 2001;91(7):343–50. PubMed
22.
Zurück zum Zitat Berger ML, Sox H, Willke RJ, Brixner DL, Eichler HG, Goettsch W, et al. Good practices for real-world data studies of treatment and/or comparative effectiveness: recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making. Value Health. 2017;20(8):1003–8. PubMed Berger ML, Sox H, Willke RJ, Brixner DL, Eichler HG, Goettsch W, et al. Good practices for real-world data studies of treatment and/or comparative effectiveness: recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making. Value Health. 2017;20(8):1003–8. PubMed
23.
Zurück zum Zitat Oberaigner W, Oberaigner K. Diabetesregister Tirol Gesamtbericht 2006–2010. Innsbruck: IET – Insitut für klinische Epidemiologie; 2011. Oberaigner W, Oberaigner K. Diabetesregister Tirol Gesamtbericht 2006–2010. Innsbruck: IET – Insitut für klinische Epidemiologie; 2011.
24.
Zurück zum Zitat Harreiter J, Roden M. Diabetes mellitus–definition, klassifikation, diagnose, screening und prävention (update 2019). Wien Klin Wochenschr. 2019;131(1):6–15. PubMed Harreiter J, Roden M. Diabetes mellitus–definition, klassifikation, diagnose, screening und prävention (update 2019). Wien Klin Wochenschr. 2019;131(1):6–15. PubMed
25.
Zurück zum Zitat Radda S, Bolz M, Egger S, Gasser-Steiner V, Kralinger M, Mennel S, et al. Diagnose, Therapie und Verlaufskontrolle der diabetischen Augenerkrankung (Update 2019). Wien Klin Wochenschr. 2019;131(1):164–8. PubMed Radda S, Bolz M, Egger S, Gasser-Steiner V, Kralinger M, Mennel S, et al. Diagnose, Therapie und Verlaufskontrolle der diabetischen Augenerkrankung (Update 2019). Wien Klin Wochenschr. 2019;131(1):164–8. PubMed
27.
Zurück zum Zitat Clodi M, Abrahamian H, Brath H, Brix J, Drexel H, Fasching P, et al. Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2019). Wien Klin Wochenschr. 2019;131(Suppl 1):27–38. PubMed Clodi M, Abrahamian H, Brath H, Brix J, Drexel H, Fasching P, et al. Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2019). Wien Klin Wochenschr. 2019;131(Suppl 1):27–38. PubMed
28.
Zurück zum Zitat Steyerberg EW. Clinical prediction models: a practical approach to development, validation, and updating. Berlin Heidelberg: Springer; 2010. Steyerberg EW. Clinical prediction models: a practical approach to development, validation, and updating. Berlin Heidelberg: Springer; 2010.
29.
Zurück zum Zitat Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet. 2005;366(9498):1719–24. PubMed Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet. 2005;366(9498):1719–24. PubMed
30.
Zurück zum Zitat Largay J. Case study: new-onset diabetes: how to tell the difference between type 1 and type 2 diabetes. Clin Diabetes. 2012;30(1):25–6. Largay J. Case study: new-onset diabetes: how to tell the difference between type 1 and type 2 diabetes. Clin Diabetes. 2012;30(1):25–6.
31.
Zurück zum Zitat Younis BB, Shahid A, Arshad R, Khurshid S, Ahmad M, Yousaf H. Frequency of foot ulcers in people with type 2 diabetes, presenting to specialist diabetes clinic at a Tertiary Care Hospital, Lahore, Pakistan. BMC Endocr Disord. 2018;18(1):53. PubMedPubMedCentral Younis BB, Shahid A, Arshad R, Khurshid S, Ahmad M, Yousaf H. Frequency of foot ulcers in people with type 2 diabetes, presenting to specialist diabetes clinic at a Tertiary Care Hospital, Lahore, Pakistan. BMC Endocr Disord. 2018;18(1):53. PubMedPubMedCentral
32.
Zurück zum Zitat Lai YJ, Hu HY, Lin CH, Lee ST, Kuo SC, Chou P. Incidence and risk factors of lower extremity amputations in people with type 2 diabetes in Taiwan, 2001–2010. J Diabetes. 2015;7(2):260–7. PubMed Lai YJ, Hu HY, Lin CH, Lee ST, Kuo SC, Chou P. Incidence and risk factors of lower extremity amputations in people with type 2 diabetes in Taiwan, 2001–2010. J Diabetes. 2015;7(2):260–7. PubMed
33.
Zurück zum Zitat Sarfo-Kantanka O, Sarfo FS, Kyei I, Agyemang C, Mbanya JC. Incidence and determinants of diabetes-related lower limb amputations in Ghana, 2010–2015—a retrospective cohort study. Bmc Endocr Disord. 2019;19(1):27. PubMedPubMedCentral Sarfo-Kantanka O, Sarfo FS, Kyei I, Agyemang C, Mbanya JC. Incidence and determinants of diabetes-related lower limb amputations in Ghana, 2010–2015—a retrospective cohort study. Bmc Endocr Disord. 2019;19(1):27. PubMedPubMedCentral
34.
Zurück zum Zitat Sheen Y‑J, Kung P‑T, Kuo W‑Y, Chiu L‑T, Tsai W‑C. Impact of the pay-for-performance program on lower extremity amputations in patients with diabetes in Taiwan. Medicine. 2018;97(41):e12759. PubMedPubMedCentral Sheen Y‑J, Kung P‑T, Kuo W‑Y, Chiu L‑T, Tsai W‑C. Impact of the pay-for-performance program on lower extremity amputations in patients with diabetes in Taiwan. Medicine. 2018;97(41):e12759. PubMedPubMedCentral
35.
Zurück zum Zitat Tseng C‑H. Prevalence of lower-extremity amputation among patients with diabetes mellitus: is height a factor? CMAJ. 2006;174(3):319–23. PubMedPubMedCentral Tseng C‑H. Prevalence of lower-extremity amputation among patients with diabetes mellitus: is height a factor? CMAJ. 2006;174(3):319–23. PubMedPubMedCentral
37.
Zurück zum Zitat Baba M, Davis WA, Davis TME. A longitudinal study of foot ulceration and its risk factors in community-based patients with type 2 diabetes: the Fremantle Diabetes Study. Diabetes Res Clin Pract. 2014;106(1):42–9. PubMed Baba M, Davis WA, Davis TME. A longitudinal study of foot ulceration and its risk factors in community-based patients with type 2 diabetes: the Fremantle Diabetes Study. Diabetes Res Clin Pract. 2014;106(1):42–9. PubMed
38.
Zurück zum Zitat Bruun C, Siersma V, Guassora AD, Holstein P, de Fine Olivarius N. Amputations and foot ulcers in patients newly diagnosed with type 2 diabetes mellitus and observed for 19 years. The role of age, gender and co-morbidity. Diabet Med. 2013;30(8):964–72. PubMed Bruun C, Siersma V, Guassora AD, Holstein P, de Fine Olivarius N. Amputations and foot ulcers in patients newly diagnosed with type 2 diabetes mellitus and observed for 19 years. The role of age, gender and co-morbidity. Diabet Med. 2013;30(8):964–72. PubMed
39.
Zurück zum Zitat Hu H, Han C‑M, Hu X‑I, Ye W‑I, Huang W‑J, Smit AJ. Elevated skin autofluorescence is strongly associated with foot ulcers in patients with diabetes: a cross-sectional, observational study of Chinese subjects. J Zhejiang Univ Sci B. 2012;13(5):372–7. PubMedPubMedCentral Hu H, Han C‑M, Hu X‑I, Ye W‑I, Huang W‑J, Smit AJ. Elevated skin autofluorescence is strongly associated with foot ulcers in patients with diabetes: a cross-sectional, observational study of Chinese subjects. J Zhejiang Univ Sci B. 2012;13(5):372–7. PubMedPubMedCentral
40.
Zurück zum Zitat Jiang Y, Wang X, Xia L, Fu X, Xu Z, Ran X, et al. A cohort study of diabetic patients and diabetic foot ulceration patients in China. Wound Rep and Reg. 2015;23(2):222–30. Jiang Y, Wang X, Xia L, Fu X, Xu Z, Ran X, et al. A cohort study of diabetic patients and diabetic foot ulceration patients in China. Wound Rep and Reg. 2015;23(2):222–30.
41.
Zurück zum Zitat Tuttolomondo A, Casuccio A, Guercio G, Maida C, Del Cuore A, Di Raimondo D, et al. Arterial stiffness, endothelial and cognitive function in subjects with type 2 diabetes in accordance with absence or presence of diabetic foot syndrome. Cardiovasc Diabetol. 2017;16(1):2. PubMedPubMedCentral Tuttolomondo A, Casuccio A, Guercio G, Maida C, Del Cuore A, Di Raimondo D, et al. Arterial stiffness, endothelial and cognitive function in subjects with type 2 diabetes in accordance with absence or presence of diabetic foot syndrome. Cardiovasc Diabetol. 2017;16(1):2. PubMedPubMedCentral
42.
Zurück zum Zitat Zhao J, Deng W, Zhang Y, Zheng Y, Zhou L, Boey J, et al. Association between serum Cystatin C and diabetic foot ulceration in patients with type 2 diabetes: a cross-sectional study. J Diabetes Res. 2016;2016:8029340. PubMedPubMedCentral Zhao J, Deng W, Zhang Y, Zheng Y, Zhou L, Boey J, et al. Association between serum Cystatin C and diabetic foot ulceration in patients with type 2 diabetes: a cross-sectional study. J Diabetes Res. 2016;2016:8029340. PubMedPubMedCentral
43.
Zurück zum Zitat Callaghan BC, Feldman E, Liu J, Kerber K, Pop-Busui R, Moffet H, et al. Triglycerides and amputation risk in patients with diabetes: ten-year follow-up in the DISTANCE study. Diabetes Care. 2011;34(3):635–40. PubMedPubMedCentral Callaghan BC, Feldman E, Liu J, Kerber K, Pop-Busui R, Moffet H, et al. Triglycerides and amputation risk in patients with diabetes: ten-year follow-up in the DISTANCE study. Diabetes Care. 2011;34(3):635–40. PubMedPubMedCentral
44.
Zurück zum Zitat Humphrey AR, Dowse GK, Thoma K, Zimmet PZ. Diabetes and nontraumatic lower extremity amputations. Incidence, risk factors, and prevention—a 12-year follow-up study in Nauru. Diabetes Care. 1996;19(7):710–4. PubMed Humphrey AR, Dowse GK, Thoma K, Zimmet PZ. Diabetes and nontraumatic lower extremity amputations. Incidence, risk factors, and prevention—a 12-year follow-up study in Nauru. Diabetes Care. 1996;19(7):710–4. PubMed
45.
Zurück zum Zitat Yang Y, Østbye T, Tan SB, Salam AZ‑H, Ong BC, Yang KS. Risk factors for lower extremity amputation among patients with diabetes in Singapore. J Diabetes Complicat. 2011;25(6):382–6. Yang Y, Østbye T, Tan SB, Salam AZ‑H, Ong BC, Yang KS. Risk factors for lower extremity amputation among patients with diabetes in Singapore. J Diabetes Complicat. 2011;25(6):382–6.
46.
Zurück zum Zitat Abbott CA, Vileikyte L, Williamson S, Carrington AL, Boulton AJ. Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care. 1998;21(7):1071–5. PubMed Abbott CA, Vileikyte L, Williamson S, Carrington AL, Boulton AJ. Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care. 1998;21(7):1071–5. PubMed
47.
Zurück zum Zitat Dekker RG 2nd, Qin C, Ho BS, Kadakia AR. The effect of cumulative glycemic burden on the incidence of diabetic foot disease. J Orthop Surg Res. 2016;11(1):143. PubMedPubMedCentral Dekker RG 2nd, Qin C, Ho BS, Kadakia AR. The effect of cumulative glycemic burden on the incidence of diabetic foot disease. J Orthop Surg Res. 2016;11(1):143. PubMedPubMedCentral
48.
Zurück zum Zitat Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis (dagger). Ann Med. 2017;49(2):106–16. PubMed Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis (dagger). Ann Med. 2017;49(2):106–16. PubMed
49.
Zurück zum Zitat Al-Rubeaan K, Al Derwish M, Ouizi S, Youssef AM, Subhani SN, Ibrahim HM, et al. Diabetic foot complications and their risk factors from a large retrospective cohort study. PLoS ONE. 2015;10(5):e124446. PubMedPubMedCentral Al-Rubeaan K, Al Derwish M, Ouizi S, Youssef AM, Subhani SN, Ibrahim HM, et al. Diabetic foot complications and their risk factors from a large retrospective cohort study. PLoS ONE. 2015;10(5):e124446. PubMedPubMedCentral
50.
Zurück zum Zitat Federation IDIDF. Diabetes Atlas. 7th ed. 2015. Federation IDIDF. Diabetes Atlas. 7th ed. 2015.
51.
Zurück zum Zitat Hu Y, Bakhotmah BA, Alzahrani OH, Wang D, Hu FB, Alzahrani HA. Predictors of diabetes foot complications among patients with diabetes in Saudi Arabia. Diabetes Res Clin Pract. 2014;106(2):286–94. PubMed Hu Y, Bakhotmah BA, Alzahrani OH, Wang D, Hu FB, Alzahrani HA. Predictors of diabetes foot complications among patients with diabetes in Saudi Arabia. Diabetes Res Clin Pract. 2014;106(2):286–94. PubMed
52.
Zurück zum Zitat Selby JV, Zhang D. Risk factors for lower extremity amputation in persons with diabetes. Diabetes Care. 1995;18(4):509–16. PubMed Selby JV, Zhang D. Risk factors for lower extremity amputation in persons with diabetes. Diabetes Care. 1995;18(4):509–16. PubMed
53.
Zurück zum Zitat Robinson TE, Kenealy T, Garrett M, Bramley D, Drury PL, Elley CR. Ethnicity and risk of lower limb amputation in people with Type 2 diabetes: a prospective cohort study. Diabet Med. 2016;33(1):55–61. PubMed Robinson TE, Kenealy T, Garrett M, Bramley D, Drury PL, Elley CR. Ethnicity and risk of lower limb amputation in people with Type 2 diabetes: a prospective cohort study. Diabet Med. 2016;33(1):55–61. PubMed
54.
Zurück zum Zitat Young BA, Maynard C, Reiber G, Boyko EJ. Effects of ethnicity and nephropathy on lower-extremity amputation risk among diabetic veterans. Diabetes Care. 2003;26(2):495–501. PubMed Young BA, Maynard C, Reiber G, Boyko EJ. Effects of ethnicity and nephropathy on lower-extremity amputation risk among diabetic veterans. Diabetes Care. 2003;26(2):495–501. PubMed
Metadaten
Titel
Diabetic foot complications—lessons learned from real-world data derived from a specialized Austrian hospital
verfasst von
Sophia Rossboth
Benedikt Rossboth
Hans Schoenherr
Christian Ciardi
Monika Lechleitner
Willi Oberaigner
Publikationsdatum
03.05.2021
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 1-2/2022
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-021-01864-5